Literature DB >> 36120204

Scrub Typhus Presenting as Acute Flaccid Paralysis in a Child: A Differential to Be Included in a Common Presentation.

Pradeep Kumar1, Arun Prasad1, Subhash Kumar2, Ambrin Akhtar1.   

Abstract

Neurological manifestations are common in scrub typhus in children. A 12-year-old girl presented with acute onset fever, bilateral lower limb weakness, and urinary retention. On initial investigations, scrub typhus immunoglobulin M (IgM) ELISA (enzyme-linked immunosorbent assay) was reactive. She was given an injection of doxycycline along with other supportive therapies. Her symptoms improved gradually and bilateral lower limb power came back gradually without residual weakness by the 13th day of admission.
Copyright © 2022, Kumar et al.

Entities:  

Keywords:  afp; doxycycline; ivig; meningoencephalitis; muscle weakness

Year:  2022        PMID: 36120204      PMCID: PMC9467491          DOI: 10.7759/cureus.27909

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


Introduction

Scrub typhus is an acute zoonotic disease caused by Orientia tsutsugamushi and transmitted by trombiculid mites [1]. Historically scrub typhus was described in Japan in the 1800 AD, and then in Japan and Malaysia in the early 20th century [2]. It is a serious public health problem in the Asia-Pacific region. As per the current estimates, it threatens one billion people globally and leads to illness in around one million people every year [3]. A high index of suspicion is required to diagnose scrub typhus infections, as the clinical features are often confused with dengue, malaria, leptospirosis, meningoencephalitis, and viral infections. Untreated cases often have a high case fatality. Bonell et al., in a systematic review, reported varying mortality reports with a median mortality of 6.0% and 1.4% for untreated and treated scrub typhus respectively. Existing evidence suggests high mortality in complicated scrub typhus with CNS (central nervous system) involvement (13.6% mortality) and multi-organ dysfunction (24.1%) [4]. Delayed treatment with doxycycline has been associated with major organ dysfunction as well as prolonged hospitalization, emphasizing that it is imperative to start early empirical doxycycline therapy in suspected cases [5]. Meningoencephalitis is the most commonly reported neurological manifestation of scrub typhus [6]. Overall, the neurological complications of scrub typhus include aseptic meningitis, meningoencephalitis, seizures, delirium, hearing loss, cerebellitis, and myelitis [7]. In scrub typhus, bacteria enter from the periphery to the central nervous system via a hematogenous route. Orientia tsutsugamushi is frequently seen in circulating mononuclear cells. There is prolonged microbial survival in leukocytes and phagocyte-facilitated infection may cause an invasion of the central nervous system [8]. Few cases of scrub typhus with GBS (Guillain-Barré syndrome) have been reported in adults [9]. We report a case of scrub typhus with meningoencephalitis who developed acute flaccid paralysis in the form of paraparesis, which improved gradually with an injection of doxycycline and other supportive therapies. Paraparesis resolved completely in two weeks and no residual weakness was noted on subsequent follow-up.

Case presentation

A 12-year-old female child was admitted with complaints of fever of 102°- 104° F for four days and muscle weakness in both lower limbs for three days with a history of urinary retention without any sensory involvement. The weakness of all groups of muscles in bilateral lower limbs developed simultaneously. The patient did not specifically appreciate any difference in the involvement of lower limb muscle groups. There was no history of ear discharge, trauma to the head or spine, contact with tuberculosis, recent intramuscular injection, snake bite, poisoning, or history of travel, outdoor camping, or playing in the forest. Rash was absent and we found no eschar after extensive search especially in the armpit, groin as well as exposed areas. Her developmental milestones were as per age. At the time of admission, the patient was conscious, oriented, and febrile, with a temperature of 102°F. Her CNS findings were a Glasgow coma scale of 15/15, hypotonia in bilateral lower limbs, 0/5 power in bilateral lower limbs, absent knee and ankle reflexes, and abdominal and plantar reflexes. Her Hughes grade was 4 and her MRC (Medical Research Council) sum score was 30/60 [10,11]. Sensory and autonomic examination revealed no problem. The total MRC sum score ranges from zero (total paralysis) to 60 (normal strength). The score is the sum of the MRC score of six muscles (three at the upper and three at the lower limbs) on both sides, each muscle graded from zero to five. The following muscles were examined: Deltoid, Biceps, Wrist extensor, Iliopsoas, Quadriceps femoris, and Tibialis anterior (Tables 1, 2).
Table 1

Hughes’ grade with subdivision of grades

Reference no. [10]

GradesFunctions
Grade 0Normal functional state
Grade 1Able to run with minor signs and symptoms
Grade 2Able to walk 5 meters independently
Grade 3Able to walk 5 meters with aid
Grade 4Bed or chair bound
Grade 5With respiratory failure
Grade 5 AWith early respiratory failure, no requirement for a ventilator
Grade 5 BRespiratory failure requiring mechanical ventilation
Grade 6Death
Table 2

Medical Research Council (MRC) sum score

Reference no. [11]

GradeDegree of Strength
5Normal Strength
4Ability to resist moderate pressure throughout a range of motion
3Ability to move through a full range of motion against gravity. If a subject has a contracture that limits joint movement, the mechanical range will be to the point at which the contracture causes joint restriction
2Ability to move through a full range of motion with gravity eliminated
1A flicker of motion is seen or felt in the muscle
0No movement

Hughes’ grade with subdivision of grades

Reference no. [10]

Medical Research Council (MRC) sum score

Reference no. [11] She was admitted to PICU (pediatric intensive care unit) and appropriate investigations were sent to establish the cause of fever and acute flaccid paralysis (AFP). Local AFP surveillance team informed as per unit protocol. IVIg (Intravenous Immunoglobulin) 2 gm/kg was given over five days suspecting AFP due to GBS. Her complete blood count was normal except for hemoglobin, which was on the lower side of normal and mild lymphocytosis. The peripheral smear showed microcytic hypochromic red cells with increased lymphocytes and no hemoparasites were noted. Liver function showed an increase in transaminases. Serum electrolytes were normal with serum calcium slightly in the lower range. Her C-reactive protein, creatinine phosphokinase, and serum ammonia were increased (Table 3).
Table 3

Laboratory investigations

PCV: packed cell volume, MCV: mean corpuscular volume, ESR: erythrocyte sedimentation rate, CPK: creatinine phosphokinase

InvestigationNormal valueDay 1Day 6Day 8
Hemoglobin (g/dL)11.5–14.5119.7 
Platelets (per cmm)150–450×103 150×103 179×103  
Leucocyte count (per cmm)4,000–11,00011,4008,310 
Differential leucocyte count (%):    
         Neutrophils40-8039.959.1 
         Lymphocytes20-4057.635.4 
         Monocytes2-101.82.0 
         Eosinophils1-602.1 
         Basophils0-10.70 
PCV (%)35-4583.787.6 
MCV (fL)78-9513.513.9 
ESR (mm in first hour)0-107043 
Total serum bilirubin (mg/dL)0.3–1.20.83 0.59
Serum direct bilirubin (mg/dL)<0.20.26 0.25
Aspartate aminotransferase (IU/L)<31125.3   83.8  
Alanine aminotransferase (IU/L)10–2869.5   137.1  
Alkaline phosphatase (IU/L)100–290103.5 112.9
Total protein6.0-8.06.90  
Albumin/Globulin (gm/dL) ratio 0.84 0.63
Blood urea (mg/dL)13–4327.5 20.6
Serum creatinine (mg/dL)0.7–1.30.47 0.37
Serum sodium (mmol/L)135–145129.2 132.7
Serum potassium (mmol/L)3.5–54.4 4.2
Serum calcium (mg/dL)8.8-10.88.2 8.4
Serum phosphate (mg/dL)3.2-5.83.5 5.2
C-reactive protein (mg/L)0-529.212.8 
CPK (IU/L)20-180256.78 200.32
Serum ammonia (µmol/L)11-32394  

Laboratory investigations

PCV: packed cell volume, MCV: mean corpuscular volume, ESR: erythrocyte sedimentation rate, CPK: creatinine phosphokinase HIV I & II (Human Immunodeficiency Virus) antibodies, HBsAg (Hepatitis B surface antigen), and Anti-HCV (Hepatitis C Virus) antibodies were non-reactive. Leptospira serology was non-reactive. Dengue NS1 (Non-structural Protein 1) antigen, IgM (Immunoglobulin M), and IgG (Immunoglobulin G) were negative but scrub typhus IgM ELISA (enzyme-linked immune sorbent assay) was reactive (Table 4).
Table 4

Serology reports

NS1: non-structural protein 1, IgM: immunoglobulin M, IgG: immunoglobulin G, ELISA: enzyme-linked immune sorbent assay, HIV: human immunodeficiency virus, HBsAg: hepatitis B surface antigen, HCV: hepatitis C virus

TestsReports
Malaria card testNegative
Dengue NS1 Antigen, IgM, IgGAll non-reactive
Leptospira IgMNon-reactive
Scrub typhus IgM ELISAReactive
HIV I & II antibodyNon-reactive
HBsAgNegative
Anti HCV antibodyNon-reactive
Widal testNegative

Serology reports

NS1: non-structural protein 1, IgM: immunoglobulin M, IgG: immunoglobulin G, ELISA: enzyme-linked immune sorbent assay, HIV: human immunodeficiency virus, HBsAg: hepatitis B surface antigen, HCV: hepatitis C virus CSF (cerebrospinal fluid) on day one showed 80% lymphocytes with 20% polymorphs and increased LDH (lactate dehydrogenase), the rest of the parameters were normal (Table 5).
Table 5

CSF examination reports on different stages of illness

CSF: cerebrospinal fluid, AFB: acid-fast bacilli, CBNAAT: Cartridge based nucleic acid amplification test, ADA: adenosine deaminase, LDH: lactate dehydrogenase

ParametersNormal valueDay 1Day 9
Volume 3ml3ml
ColourColorlessColorlessColorless
AppearanceClearClearClear
Cells (mm3)<5202
     Lymphocytes≥75%80%100%
     Polymorphs020% 
Gram stainingNegativeNegativeNegative
AFB stainingNegativeNegativeNegative
CBNAATNegativeNegativeNegative
Culture and sensitivityNo growthNo growthNo growth
Protein (mg/dL)20-4557.5536.10
Sugar (mg/dL)>50 (or 75% serum glucose)5970.04
ADA (IU/L)< 102.76< 0.10
LDH (IU/L)< 4089.8533.95

CSF examination reports on different stages of illness

CSF: cerebrospinal fluid, AFB: acid-fast bacilli, CBNAAT: Cartridge based nucleic acid amplification test, ADA: adenosine deaminase, LDH: lactate dehydrogenase Intravenous (IV) doxycycline was started for scrub typhus. Other supportive therapies like IV paracetamol for fever and intravenous fluids were also started. We had initially started 3% saline considering raised intracranial pressure as meningoencephalitis is the most common neurological involvement, which was later stopped in view of no clinical or CSF features suggestive of the same. Nerve conduction velocity was also done which was normal. The patient developed warm shock on the next day, hence noradrenaline was started. Blood culture showed no growth. CSF study was repeated on day nine of illness and the reports were normal on all parameters. Her MRI (Magnetic Resonance Imaging) brain and spine were reported to be normal (Figure 1).
Figure 1

MRI brain and spine

MRI (Magnetic Resonance Imaging) brain and spine

A) Axial FLAIR (fluid-attenuated inversion recovery) image of brain showing normal appearance of the brain parenchyma (white arrow)

B) Axial post-contrast T1-FS image of the brain showing the normal appearance, without any abnormal meningeal or parenchymal enhancement (white arrow)

C) Sagittal post-contrast T1-FS image of the whole spine showing the normal appearance, without any abnormal meningeal or spinal cord enhancement (white arrow)

MRI brain and spine

MRI (Magnetic Resonance Imaging) brain and spine A) Axial FLAIR (fluid-attenuated inversion recovery) image of brain showing normal appearance of the brain parenchyma (white arrow) B) Axial post-contrast T1-FS image of the brain showing the normal appearance, without any abnormal meningeal or parenchymal enhancement (white arrow) C) Sagittal post-contrast T1-FS image of the whole spine showing the normal appearance, without any abnormal meningeal or spinal cord enhancement (white arrow) X-ray chest was also normal. Routine examination of urine did not show any abnormality. The patient gradually improved with an injection of doxycycline and other supportive therapy. She recovered from warm shock gradually and her power in bilateral lower limbs improved from 0/5 to 2/5 on day four, 3/5 on day nine, and 5/5 by day twelve, and discharged on day 13 with no residual weakness (Table 6).
Table 6

Improvement in neurological parameters

MRC: medical research council, UL: upper limbs, LL: lower limbs

Neurological parametersDay1Day 4Day 9Day 13
MRC sum score30/6038/6054/6060/60
Hughes’ score4430
Muscle power UL5/55/55/55/5
Muscle power LL0/52/53/55/5
ReflexesAreflexiaAreflexiaNormalNormal

Improvement in neurological parameters

MRC: medical research council, UL: upper limbs, LL: lower limbs

Discussion

Scrub typhus is an important cause of acute febrile illness and is rampant in Asian countries. It is reported to have wider distribution across South America and Africa [4]. It has a whole gamut of neurological manifestations. Meningoencephalitis is one of the commonest neurological manifestations [6]. We found reports of acute transverse myelitis and GBS more common in adults than in children. We found one case report of exclusive paraparesis in children after an extensive search of published literature to date. Gangula et al. reported GBS in a 40-year-old male patient with scrub typhus and Plasmodium falciparum infection simultaneously [9]. Dev et al. have reported GBS in a 20 years old male patient who had concurrent scrub typhus and leptospira infection as well [12]. In our case, we could not establish GBS, as there was no involvement of the upper limbs suggestive of ascending paralysis. Also, there was no albumin-cytological dissociation in the second CSF examination during the second week of illness and the nerve conduction velocity was normal too. Ryu et al. found paraparesis in a 66 years old patient who was found to have eschar, the motor weakness recovered completely in five days of steroid pulse therapy and seven days of injectable doxycycline, but urinary retention persisted even after one year of follow-up [13]. Lee et al. reported acute transverse myelitis in a 54-years-old male patient suffering from scrub typhus with eschar and was controlled voiding on alpha-adrenergic blockers [14]. Tandon et al. in 2022 reported long‑segment myelitis, meningoencephalitis, and axonal polyneuropathy in a 17-year-old adolescent who had co-infection of neurocysticercosis. The authors report residual weakness after three months of follow-up [15]. Muranjan and Karande reported a case of acute paraparesis due to lumbosacral radiculopathy with concomitant meningitis in a 13-month-old child who recovered completely without residual paraparesis in the second month of illness [16]. In our patient, who was a 12-year-old girl, we found evidence of meningitis with normal neuroimaging of the brain and spine. The reported literature suggests residual weakness in most cases of paraparesis in adults and adolescents, our patient had clinical AFP involving bilateral lower limbs, which recovered fully by the end of the second week of illness.

Conclusions

Scrub typhus should also be considered in the differential diagnosis of acute flaccid paraparesis, especially when it is associated with an altered mental state, or clinical and CSF-proven meningoencephalitis in rickettsia endemic areas. It is a fatal disease but responds well to the available medications (doxycycline or azithromycin). Most of the cases recover well without residual weakness. Fatality reduces significantly if prompt treatment is started before the development of hypotensive shock.
  16 in total

Review 1.  Scrub typhus: the geographic distribution of phenotypic and genotypic variants of Orientia tsutsugamushi.

Authors:  Daryl J Kelly; Paul A Fuerst; Wei-Mei Ching; Allen L Richards
Journal:  Clin Infect Dis       Date:  2009-03-15       Impact factor: 9.079

2.  Guillain-Barre Syndrome with Falciparum Malaria and Scrub Typhus Mixed Infection-An Unusual Combination.

Authors:  Rahul Sai Gangula; Weena Stanley; Arunsheshu Vandanapu; M Mukhyaprana Prabhu
Journal:  J Clin Diagn Res       Date:  2017-09-01

3.  Acute transverse myelitis following scrub typhus: A case report and review of the literature.

Authors:  Hyun-Seung Ryu; Bong Ju Moon; Jae-Young Park; Sang-Deok Kim; Seung-Kwon Seo; Jung-Kil Lee
Journal:  J Spinal Cord Med       Date:  2018-01-19       Impact factor: 1.985

Review 4.  Invasion of the central nervous system by intracellular bacteria.

Authors:  Douglas A Drevets; Pieter J M Leenen; Ronald A Greenfield
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

5.  Endemic Scrub Typhus in South America.

Authors:  Thomas Weitzel; Sabine Dittrich; Javier López; Weerawat Phuklia; Constanza Martinez-Valdebenito; Katia Velásquez; Stuart D Blacksell; Daniel H Paris; Katia Abarca
Journal:  N Engl J Med       Date:  2016-09-08       Impact factor: 91.245

6.  A clinical prognostic scoring system for Guillain-Barré syndrome.

Authors:  Rinske van Koningsveld; Ewout W Steyerberg; Richard A C Hughes; Anthony V Swan; Pieter A van Doorn; Bart C Jacobs
Journal:  Lancet Neurol       Date:  2007-07       Impact factor: 44.182

7.  Clinical predictive value of manual muscle strength testing during critical illness: an observational cohort study.

Authors:  Bronwen A Connolly; Gareth D Jones; Alexandra A Curtis; Patrick B Murphy; Abdel Douiri; Nicholas S Hopkinson; Michael I Polkey; John Moxham; Nicholas Hart
Journal:  Crit Care       Date:  2013-10-10       Impact factor: 9.097

Review 8.  A review of the global epidemiology of scrub typhus.

Authors:  Guang Xu; David H Walker; Daniel Jupiter; Peter C Melby; Christine M Arcari
Journal:  PLoS Negl Trop Dis       Date:  2017-11-03

Review 9.  Estimating the burden of scrub typhus: A systematic review.

Authors:  Ana Bonell; Yoel Lubell; Paul N Newton; John A Crump; Daniel H Paris
Journal:  PLoS Negl Trop Dis       Date:  2017-09-25

10.  Long-Segment Myelitis, Meningoencephalitis, and Axonal Polyneuropathy in a Case of Scrub Typhus.

Authors:  Ruchika Tandon; Amit Kumar; Ajay Kumar
Journal:  Ann Indian Acad Neurol       Date:  2019 Apr-Jun       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.